0 Times "estrogen dominance" appears as a diagnosis in endocrinology clinical guidelines: it is a wellness term, not a medical one
1 in 10 Women have endometriosis: a condition associated with relative estrogen excess, yet diagnosis takes an average of 7 years
Perimenopause Is the most common real-world cause of relative estrogen excess: driven by falling progesterone before estrogen declines

Where does the term come from, and what does it actually mean?

A doctor named John Lee invented "estrogen dominance" in the 1990s to describe an imbalance: when estrogen's effects outweigh progesterone's. It happens two ways: estrogen is genuinely high, or progesterone is low while estrogen stays normal. Both create a relative excess of estrogen effects.

Here's what most doctors don't mention: clinical endocrinology completely ignores this term. Endocrinologists recognize specific, diagnosable conditions (perimenopause, PCOS, endometriosis, fibroids) with different hormone profiles and evidence-based management. The wellness industry's problem: it treats "estrogen dominance" as a single catch-all diagnosis, usually without blood testing, and sells supplements with no evidence. Most women self-diagnose online instead of getting proper hormone testing. That's the gap.

Research Note

Relative estrogen excess is a genuine concept in reproductive endocrinology. Anovulatory cycles (when ovulation doesn't occur) produce estrogen without a corpus luteum and therefore without the progesterone surge that follows ovulation. This is common in perimenopause and in conditions like PCOS. The result is prolonged, unopposed estrogen stimulation of the uterine lining. Which is clinically significant and a focus of gynecological management.

What conditions actually involve relative estrogen excess?

Perimenopause is the most common driver. Your 40s bring sporadic ovulation: skipped cycles, anovulatory cycles. Progesterone drops before estrogen does. This creates a genuine window of estrogen-relative-to-progesterone excess. You get heavier periods, breast tenderness, mood chaos. This is measurable, diagnosable, and manageable.

Endometriosis thrives on estrogen. Tissue outside your uterus is estrogen-sensitive and actually shrinks when estrogen drops. Fibroids are similar: estrogen-dependent growths. PCOS is different. It involves elevated androgens and altered estrogen metabolism, not simple estrogen excess. Fibroids, endometriosis, PCOS, perimenopause. All different. All need different approaches. Self-diagnosing as "estrogen dominant" applies to none of them.

Key Distinction

There is an important difference between absolute estrogen excess (estrogen levels genuinely high on blood testing) and relative estrogen excess (normal estrogen with low progesterone). Wellness content rarely makes this distinction, but clinically, they have different causes and different management. Standard blood tests can begin to clarify which, if either, applies to you.

What about the supplements and protocols sold for it?

DIM, calcium d-glucarate, vitex, liver support formulas. They're all marketed for estrogen dominance. The evidence? Thin. DIM affects estrogen metabolism in test tubes, but human trials showing it actually helps are weak and poorly designed. Vitex has some evidence for a properly diagnosed short luteal phase, but it's not a magic hormone balancer.

What to ask your doctor

🩺

Real symptoms deserve real investigation

If you have symptoms being attributed to "estrogen dominance" by wellness sources, they deserve proper medical evaluation. Not because the symptoms aren't real, but because self-diagnosing from a non-clinical framework may delay finding an actual diagnosis (such as endometriosis, PCOS, or perimenopause) that has proper management options. Ask your doctor for a referral to a OB-GYN or reproductive endocrinologist.

Medical Disclaimer: This article is for informational and educational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.

References

  1. Prior JC. Progesterone for Symptomatic Perimenopause Treatment — Progesterone politics, physiology and potential for perimenopause. Facts Views Vis Obgyn. 2011;3(2):109-120. PMC
  2. Bulun SE. Endometriosis. N Engl J Med. 2009;360(3):268-279. PubMed
  3. Zeleke BM, Davis SR, Fradkin P, Bell RJ. Vasomotor symptoms and urogenital atrophy in older women: a systematic review. Climacteric. 2015;18(1):112-120. PubMed